openRxiv
TREM2 mediates MHCII-associated CD4 + T cell response against gliomas
Preprints
Zheng, J; Wang, L; Zhao, S; Zhang, W; Chang, Y; Dheer, A; Gao, S; Xu, S; Ayasoufi, K; Al-kharboosh, R; Xie, M; Johnson, AJ; Dong, H; Wu, L-J ...
April 6, 2023
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Citation
APA
Chicago
ICMJE
MLA
NLM
Zheng, J., Wang, L., Zhao, S., Zhang, W., Chang, Y., Dheer, A., … Wu, L.-J. (2023). TREM2 mediates MHCII-associated CD4
+
T cell response against gliomas. openRxiv. https://doi.org/10.1101/2023.04.05.535697
Zheng, Jiaying, Lingxiao Wang, Shunyi Zhao, Wenjing Zhang, Yuzhou Chang, Aastha Dheer, Shan Gao, et al. “TREM2 mediates MHCII-associated CD4
+
T cell response against gliomas.” OpenRxiv, April 6, 2023. https://doi.org/10.1101/2023.04.05.535697.
Zheng J, Wang L, Zhao S, Zhang W, Chang Y, Dheer A, et al. TREM2 mediates MHCII-associated CD4
+
T cell response against gliomas. openRxiv. 2023.
Zheng, Jiaying, et al. “TREM2 mediates MHCII-associated CD4
+
T cell response against gliomas.” OpenRxiv, 6 Apr. 2023. Crossref, doi:10.1101/2023.04.05.535697.
Zheng J, Wang L, Zhao S, Zhang W, Chang Y, Dheer A, Gao S, Xu S, Ayasoufi K, Al-kharboosh R, Xie M, Johnson AJ, Dong H, Quiñones-Hinojosa A, Wu L-J. TREM2 mediates MHCII-associated CD4
+
T cell response against gliomas. openRxiv. 2023.